www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
 PUBLICATIONS
PRESS RELEASES
ANNUAL REPORTS
CONTACT

 
 
To view our documents, you must use PDF software.
All documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
(Intranasal Recombinant Human Insulin)
Open Nasulin Publication
November 2, 2009 | 37 pages
 
 
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
 
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
 
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101